Henrik Jespersen

7PUBLICATIONS
18CO-AUTHORS
Molecular targetsGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 28, 2021
The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma.

Lars Ny, Henrik Jespersen, Joakim Karlsson

|Nov 30, 2020
Surgery of metastatic melanoma after systemic therapy - the SUMMIST trial: study protocol for a randomized controlled trial.

Carl Jacob Holmberg, Dimitrios Katsarelias, Henrik Jespersen

|Apr 22, 2020
Molecular profiling of driver events in metastatic uveal melanoma.

Joakim Karlsson, Lisa M Nilsson, Suman Mitra

|Jun 02, 2019
Real-world data on PD-1 inhibitor therapy in metastatic melanoma.

Anna Arheden, Joanna Skalenius, Sara Bjursten

Pageof 2